Plasma from patients 1, 7, and 14 days after pneumonia diagnosis drives tau aggregation in these assays, indicating that circulating tau variants are cytotoxic (Lin MT, unpublished observations). This evidence concerns the gene MAPT and susceptibility to pneumonia measurement.